|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US5288641A
(en)
|
1984-06-04 |
1994-02-22 |
Arch Development Corporation |
Herpes Simplex virus as a vector
|
|
CA1341423C
(en)
|
1984-10-31 |
2003-03-04 |
Paul A. Luciw |
Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
|
|
ZA8681B
(en)
|
1985-01-07 |
1987-08-26 |
Syntex Inc |
1,2-dialkoxy-omega-trialkylammonium cationic surfactants
|
|
GB8508845D0
(en)
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
|
US5091309A
(en)
|
1986-01-16 |
1992-02-25 |
Washington University |
Sindbis virus vectors
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
WO1989001973A2
(en)
|
1987-09-02 |
1989-03-09 |
Applied Biotechnology, Inc. |
Recombinant pox virus for immunization against tumor-associated antigens
|
|
US5591624A
(en)
|
1988-03-21 |
1997-01-07 |
Chiron Viagene, Inc. |
Retroviral packaging cell lines
|
|
US5716826A
(en)
|
1988-03-21 |
1998-02-10 |
Chiron Viagene, Inc. |
Recombinant retroviruses
|
|
US5217879A
(en)
|
1989-01-12 |
1993-06-08 |
Washington University |
Infectious Sindbis virus vectors
|
|
CA2357538A1
(en)
|
1989-03-21 |
1990-10-04 |
Wisconsin Alumni Research Foundation |
Expression of exogenous polynucleotide sequences in a vertebrate
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
CA2017507C
(en)
|
1989-05-25 |
1996-11-12 |
Gary Van Nest |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5817491A
(en)
|
1990-09-21 |
1998-10-06 |
The Regents Of The University Of California |
VSV G pseusdotyped retroviral vectors
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
AU671971B2
(en)
|
1991-11-29 |
1996-09-19 |
Chiron Corporation |
Anti-cancer immunotherapeutic vector constructs
|
|
EP0671948B1
(en)
|
1992-06-25 |
1997-08-13 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccine composition containing adjuvants
|
|
IL107366A
(en)
|
1992-10-23 |
2003-03-12 |
Chugai Pharmaceutical Co Ltd |
Genes coding for megakaryocyte potentiator
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US5651981A
(en)
|
1994-03-29 |
1997-07-29 |
Northwestern University |
Cationic phospholipids for transfection
|
|
US5527928A
(en)
|
1994-09-30 |
1996-06-18 |
Nantz; Michael H. |
Cationic transport reagents
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
CA2241604C
(en)
|
1996-01-05 |
2010-03-30 |
Ira Pastan |
Mesothelium antigen and methods and kits for targeting it
|
|
US7375183B1
(en)
|
1996-01-05 |
2008-05-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Mesothelin, immunogenic peptides derived therefrom, and compositions comprising mesothelin, or immunogenic peptides thereof
|
|
AU734253B2
(en)
|
1996-03-20 |
2001-06-07 |
Sloan-Kettering Institute For Cancer Research |
Conjugated mucin peptide vaccines
|
|
US6475789B1
(en)
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
US6093809A
(en)
|
1996-10-01 |
2000-07-25 |
University Technology Corporation |
Telomerase
|
|
IL129222A0
(en)
|
1996-10-01 |
2000-02-17 |
Geron Corp |
Telomerase reverse transcriptase
|
|
US6261836B1
(en)
|
1996-10-01 |
2001-07-17 |
Geron Corporation |
Telomerase
|
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
EP1039935A4
(en)
|
1997-02-28 |
2005-04-27 |
Univ Iowa Res Found |
USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
|
|
EP2172216A3
(en)
|
1997-03-10 |
2010-11-24 |
Ottawa Hospital Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US20050013825A1
(en)
|
1997-04-18 |
2005-01-20 |
Geron Corporation |
Vaccine containing the catalytic subunit of telomerase for treating cancer
|
|
US7622549B2
(en)
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
ATE370740T1
(de)
|
1997-05-20 |
2007-09-15 |
Ottawa Health Research Inst |
Verfahren zur herstellung von nukleinsäurekonstrukten
|
|
EP2085090A3
(en)
|
1997-06-06 |
2012-05-02 |
The Regents of the University of California |
Inhibitors of DNA immunostimulatory sequence activity
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
DE69838992T2
(de)
|
1997-09-05 |
2008-12-24 |
Glaxosmithkline Biologicals S.A., Rixensart |
Öl-in-Wasser Emulsionen mit Saponinen
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
US6337200B1
(en)
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
WO1999052549A1
(en)
|
1998-04-09 |
1999-10-21 |
Smithkline Beecham Biologicals S.A. |
Adjuvant compositions
|
|
US6962790B1
(en)
|
1998-09-23 |
2005-11-08 |
University Of Massachusetts Medical Center |
Predictive assay for immune response
|
|
EE05627B1
(et)
|
1998-12-23 |
2013-02-15 |
Pfizer Inc. |
CTLA-4 vastased inimese monoklonaalsed antikehad
|
|
IL145043A0
(en)
|
1999-03-19 |
2002-06-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
TR200103018T2
(tr)
|
1999-04-19 |
2002-02-21 |
Beecham Biologicals S.A. Smithkline |
İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri.
|
|
US6472028B1
(en)
|
1999-08-12 |
2002-10-29 |
Joseph Frazzitta |
Method of producing a high gloss coating on a printed surface
|
|
EP1212422B1
(en)
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
|
CA2383110A1
(en)
|
1999-09-24 |
2001-03-29 |
Veronique Henderickx |
Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one non-ionic surfactant
|
|
EP1221971A2
(en)
|
1999-09-24 |
2002-07-17 |
SmithKline Beecham Biologics SA |
Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
|
|
GB9930359D0
(en)
|
1999-12-22 |
2000-02-09 |
Glaxo Group Ltd |
Novel polypeptides
|
|
AU2001241533A1
(en)
|
2000-02-15 |
2001-08-27 |
The Regents Of The University Of California |
A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
|
|
AU2001282290A1
(en)
|
2000-08-17 |
2002-03-04 |
University Of Wales College Of Medicine |
Htert-immortalised cell lines, their preparation and use
|
|
US20040136963A1
(en)
|
2001-06-22 |
2004-07-15 |
The Trustees Of The University Of Pennsylvania |
Simian adenovirus vectors and methods of use
|
|
WO2003038047A2
(en)
|
2001-10-29 |
2003-05-08 |
Baylor College Of Medicine |
Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen
|
|
TWI228718B
(en)
|
2001-11-05 |
2005-03-01 |
Tdk Corp |
Manufacturing method and device of mold plate for information medium
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
GB0212046D0
(en)
*
|
2002-05-24 |
2002-07-03 |
Glaxo Group Ltd |
Vaccines
|
|
US9200036B2
(en)
|
2002-07-12 |
2015-12-01 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
JP2006521090A
(ja)
|
2002-07-12 |
2006-09-21 |
ザ ジョンズ ホプキンス ユニバーシティー |
メゾテリンワクチンおよびモデルシステム
|
|
CN1315536C
(zh)
*
|
2002-09-13 |
2007-05-16 |
李进 |
肿瘤抗原疫苗及其制备方法和疫苗组合物
|
|
EP2163260B1
(en)
|
2004-01-23 |
2017-03-15 |
MSD Italia S.r.l. |
Chimpanzee adenovirus vaccine carriers
|
|
DE102004035227A1
(de)
|
2004-07-21 |
2006-02-16 |
Curevac Gmbh |
mRNA-Gemisch zur Vakzinierung gegen Tumorerkrankungen
|
|
US7829294B2
(en)
*
|
2004-12-28 |
2010-11-09 |
Daiichi Pure Chemicals Co., Ltd. |
Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody
|
|
EP1748067A1
(en)
|
2005-07-29 |
2007-01-31 |
Institut Pasteur |
Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
|
|
AU2007215501A1
(en)
|
2006-01-19 |
2007-08-23 |
The Regents Of The University Of California |
Human telomerase reverse transcriptase peptides
|
|
AU2007306368B2
(en)
*
|
2006-10-12 |
2012-05-03 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Telomerase reverse transcriptase fusion protein, nucleotides encoding it, and uses thereof
|
|
EP1994942A1
(en)
|
2007-05-25 |
2008-11-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Pharmaceutical compositions comprising telomerase, and uses thereof
|
|
WO2009025871A1
(en)
|
2007-08-23 |
2009-02-26 |
University Of Medicine And Dentistry Of Nj |
Telomerase reverse transcriptase variant
|
|
WO2009046738A1
(en)
*
|
2007-10-09 |
2009-04-16 |
Curevac Gmbh |
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
|
|
RS57132B1
(sr)
|
2008-07-08 |
2018-07-31 |
Incyte Holdings Corp |
1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze
|
|
EP3385387B1
(en)
|
2009-02-02 |
2021-08-25 |
GlaxoSmithKline Biologicals SA |
Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
|
|
CN101920009B
(zh)
|
2010-03-06 |
2012-08-08 |
河北医科大学 |
一种用于预防和治疗肿瘤的疫苗
|
|
CA2874998A1
(en)
*
|
2011-05-27 |
2012-12-06 |
Cytocure Llc |
Methods, compositions, and kits for the treatment of cancer
|
|
KR20140054140A
(ko)
|
2011-07-27 |
2014-05-08 |
베일러 리서치 인스티튜트 |
췌장암에 대한 수지상 세포(ｄｃ) - 백신 치료요법
|
|
US8523590B2
(en)
*
|
2011-07-29 |
2013-09-03 |
General Electric Company |
Cable system and methods of assembling a cable system
|
|
CA2844500C
(en)
*
|
2011-08-17 |
2022-05-10 |
Globeimmune, Inc. |
Yeast-muc1 immunotherapeutic compositions and uses thereof
|
|
NZ701324A
(en)
*
|
2012-05-04 |
2016-09-30 |
Pfizer |
Prostate-associated antigens and vaccine-based immunotherapy regimens
|
|
US10184216B2
(en)
*
|
2012-07-18 |
2019-01-22 |
Thomas Urbanek |
Advantageous detectable warning area and methods of forming the same
|
|
US20140234351A1
(en)
*
|
2013-02-14 |
2014-08-21 |
Immunocellular Therapeutics, Ltd. |
Cancer vaccines and vaccination methods
|
|
MX369709B
(es)
|
2013-03-15 |
2019-11-19 |
Univ Pennsylvania |
Vacunación mejorada contra tirosinasa.
|
|
MY196581A
(en)
*
|
2013-11-01 |
2023-04-19 |
Pfizer |
Vectors for Expression of Prostate-Associated Antigens
|
|
CN106536480B
(zh)
|
2014-05-15 |
2019-09-03 |
艾特奥斯治疗公司 |
吡咯烷-2,5-二酮衍生物、药物组合物及用作ido1抑制剂的方法
|